The Clinical Core will be led by Ramnik Xavier (Director), Andrew Chan (Co-Director), and Ashwin Ananthakrishnan (Technical Director). The services offered by the Clinical Core can be organized into (1) consultation, training, and education; (2) biospecimen services; and (3) data collection and analysis services. Consultation and education take the form of consulting in research methods and analysis, as well as education and training of junior investigators, residents, and fellows. Biospecimen services include clinical database and patient identification, biospecimen collection and processing services, tissue biorepository services, and serum biobank services. Data collection and analysis is facilitated through regulatory services, a genotype and microbiome library, and bioinformatics support. This core serves as a hub for interactions between clinicians and basic researchers, allowing basic scientists to test hypotheses in human samples and clinicians to gain valuable insight into disease states.
The specific aims of the Clinical Core are to (1) build a biorepository of patients with Crohn?s disease and ulcerative colitis with accurate phenotyping of disease as well as sampling of blood, stool, urine, and tissue in various disease states (active/inactive disease) and related to various therapeutic and environmental perturbations; (2) define the phenotypic implications of genetic loci with regard to clinical manifestations, response to therapy, and to examine the interaction with the environment; (3) facilitate education and training in research by providing consultations regarding study design, methods, and analysis as well as attract new investigators to the field through these services; and (4) translate laboratory and clinical research findings into interventions that serve to improve diagnosis, develop biomarkers for disease monitoring and prognostication, and optimize treatment algorithms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-30
Application #
9848616
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Cai, Tianrun; Lin, Tzu-Chieh; Bond, Allison et al. (2018) The Association Between Arthralgia and Vedolizumab Using Natural Language Processing. Inflamm Bowel Dis 24:2242-2246
Ganna, Andrea; Satterstrom, F Kyle; Zekavat, Seyedeh M et al. (2018) Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. Am J Hum Genet 102:1204-1211
Vandoorne, Katrien; Rohde, David; Kim, Hye-Yeong et al. (2018) Imaging the Vascular Bone Marrow Niche During Inflammatory Stress. Circ Res 123:415-427
Kearney, Sean M; Gibbons, Sean M; Poyet, Mathilde et al. (2018) Endospores and other lysis-resistant bacteria comprise a widely shared core community within the human microbiota. ISME J 12:2403-2416
Sayeed, Md Abu; Islam, Kamrul; Hossain, Motaher et al. (2018) Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. PLoS Negl Trop Dis 12:e0006286
Maehara, Takashi; Mattoo, Hamid; Mahajan, Vinay S et al. (2018) The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo. Life Sci Alliance 1:
Kruger, Annie J; Fuchs, Bryan C; Masia, Ricard et al. (2018) Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis. Hepatol Commun 2:529-545
Islam, Kamrul; Hossain, Motaher; Kelly, Meagan et al. (2018) Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Negl Trop Dis 12:e0006376
Lidofsky, Anna; Holmes, Jacinta A; Feeney, Eoin R et al. (2018) Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis 218:1394-1403
Nalagatla, Niharika; Falloon, Katherine; Tran, Gloria et al. (2018) Effect of Accelerated Infliximab Induction on Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-Analysis. Clin Gastroenterol Hepatol :

Showing the most recent 10 out of 1166 publications